VINEETLAB

Vineet Laboratories Share Price

 

 

Start SIP in VINEETLAB

Start SIP

Performance

  • Low
  • ₹34
  • High
  • ₹35
  • 52 Week Low
  • ₹22
  • 52 Week High
  • ₹52
  • Open Price₹35
  • Previous Close₹35
  • Volume74,438
  • 50 DMA₹35.47
  • 100 DMA₹34.29
  • 200 DMA₹34.17

Investment Returns

  • Over 1 Month + 2.31%
  • Over 3 Month + 1.89%
  • Over 6 Month + 25.34%
  • Over 1 Year -28.47%

Smart Investing Starts Here Start SIP with Vineet Laboratories for Steady Growth!

Invest Now

Vineet Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -4
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 67
  • P/B Ratio
  • 1.5
  • Average True Range
  • 1.88
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • -0.08
  • RSI
  • 46.85
  • MFI
  • 56.84

Vineet Laboratories Financials

Vineet Laboratories Technicals

EMA & SMA

Current Price
₹35.02
+ 0.38 (1.1%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹35.61
  • 50 Day
  • ₹35.47
  • 100 Day
  • ₹34.29
  • 200 Day
  • ₹34.17

Resistance and Support

34.88 Pivot Speed
  • R3 36.91
  • R2 36.19
  • R1 35.60
  • S1 34.29
  • S2 33.57
  • S3 32.98

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Vineet Laboratories has an operating revenue of Rs. 57.04 Cr. on a trailing 12-month basis. An annual revenue de-growth of -49% needs improvement, Pre-tax margin of -28% needs improvement, ROE of -137% is poor and needs improvement. The company has a reasonable debt to equity of 26%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its 50DMA and around 14% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. It is currently FORMING a base in its weekly chart and is trading around 17% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 52 which is a POOR score indicating inconsistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 69 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Vineet Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-11-27 Right issue of Equity Shares
2025-11-08 Quarterly Results
2025-07-22 Quarterly Results
2025-05-12 Audited Results
2025-02-12 Quarterly Results
Date Purpose Remarks
2022-09-20 FINAL Rs.1.00 per share(10%)Final Dividend
View Vineet Laboratories Dividend History Arrow

Vineet Laboratories F&O

Vineet Laboratories Shareholding Pattern

15.89%
78.17%
5.94%

About Vineet Laboratories

  • NSE Symbol
  • VINEETLAB
  • BSE Symbol
  • 543298
  • Managing Director
  • Mr. Gaddam Venkata Ramana
  • ISIN
  • INE505Y01010

Similar Stocks to Vineet Laboratories

Vineet Laboratories FAQs

Vineet Laboratories share price is ₹35 As on 11 January, 2026 | 02:31

The Market Cap of Vineet Laboratories is ₹67.3 Cr As on 11 January, 2026 | 02:31

The P/E ratio of Vineet Laboratories is -4 As on 11 January, 2026 | 02:31

The PB ratio of Vineet Laboratories is 1.5 As on 11 January, 2026 | 02:31

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23